CLINICAL_TRIALS
trial_result
· 2025-06-18
Clinical Trial Update: A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS [Phase 2]
Summary
A Phase 2 trial evaluating AL001 in C9orf72-associated amyotrophic lateral sclerosis has been terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alector Inc. | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2025-06-18